Molecule intelOpportunity: ModerateEssential

Granisetron

16 brands · 12 companies · product forms

ATC: A04AA02

Opportunity snapshot

Launch attractiveness
49
Market saturation
31
Price room
100
Regulatory risk
0
16
brands
12
companies
Rs 741.36
median price
10
price points
12.18x
price spread
100
confidence %

Who competes here

Top companies by brand count · leader share 25%

Price room

Across observed sources and strengths
CheapestRs 529.55
MedianRs 741.36
Most expensiveRs 6,448.42
Spread12.18×
Sources: DRAP-official

max/min price ratio 12.18x across 10 trusted points (Rs 529.55-6448.42). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 3 live products for Granisetron — each links to its own medicine page.

Why this score

Launch attractiveness

40% supply-gap(25) + 25% price-variation(100) + 20% low-competition(69) + 15% supply-disruption(0), damped by confidence(100). Higher = more attractive, less crowded opportunity.

Market saturation

12 canonical companies and 16 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 12.18x across 10 trusted points (Rs 529.55-6448.42). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

No DRAP alerts on this molecule's brands.

Confidence

Full coverage.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.